Company profile: Reveal Biosciences
1.1 - Company Overview
Company description
- Provider of computational pathology diagnostics using AI to analyze large whole slide microscope images, combining a histopathology laboratory with machine learning to diagnose disease. Offers a new class of diagnostics with fundamental improvements in reach, cost, speed, accuracy, and scale in disease diagnosis.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Reveal Biosciences
Mologic
HQ: United Kingdom
Website
- Description: Provider of point-of-care diagnostic solutions, offering contract research for assay and antibody development, flexible manufacturing of lateral flow diagnostics, and a portfolio of rapid tests for health issues including yellow fever and chronic obstructive pulmonary disorder. Also partners with governments and organizations to distribute diagnostics globally, focusing on areas with significant need.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mologic company profile →
Brooks Running
HQ: United States
Website
- Description: Provider of automation, vacuum, and instrumentation solutions for the worldwide semiconductor manufacturing industry, including wafer handling robotics and integrated tool automation systems, vacuum and atmospheric robots, configurable transfer and transport platforms (MagnaTran LEAP, Marathon LEAP AX, Marathon Express), and pathology lab automation (PathFinder Benchtop, Tube Decapper).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Brooks Running company profile →
Trace Genomics
HQ: United States
Website
- Description: Provider of soil health and microbiome analysis using next-generation sequencing to deliver genetic insights into soil for optimizing agricultural practices, crop yield, and sustainability. Offerings include TraceCOMPLETE (pathogen, fertility, and soil management insights), TraceCARBON (soil carbon stocks), metagenomics, hi-definition DNA and chemical soil analysis, and a farm data privacy and protection policy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trace Genomics company profile →
BioServ
HQ: United Kingdom
Website
- Description: Provider of biotechnology services specializing in upstream production and downstream processing of antibodies and other proteins.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioServ company profile →
Definigen
HQ: United Kingdom
Website
- Description: Provider of in-vitro liver and metabolic disease models using iPSC technology to generate pre-clinical human data, offering Opti-HEPs for drug efficacy and predictive toxicology screening, phenotypic screening with bioassays, and custom disease model development via CRISPR. Includes models for Alpha-1 Antitrypsin Deficiency, Wilson's Disease (ATP7B), and Glycogen Storage Disease Type 1 Alpha.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Definigen company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Reveal Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Reveal Biosciences
2.2 - Growth funds investing in similar companies to Reveal Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Reveal Biosciences
4.2 - Public trading comparable groups for Reveal Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →